“Make a Difference” is how my father Ron Johnson approached life. Humanitarian, businessman, and sportsman; Ron worked to make the people and organizations around him better. In June 2008 Ron was diagnosed with early-onset Alzheimer’s at the age of 60. Suddenly he faced a cruel challenge that would slow down and diminish his ability to advance positive change around him. Alzheimer’s does not discriminate on age, gender, or vibrancy. In fact, too often the disease halts those in our communities who do so much good and have so much unfinished work to positively improve our communities. Absent from my wedding, the birth of my three children, and career milestones; the harshest consequence that Alzheimer’s had on my father, life events he looked forward to joining.
Ron passed away on November 10, 2018 after ten long and challenging years fighting Alzheimer’s.
In 2011 I joined the Alzheimer’s Drug Discovery Foundation (“ADDF”) to Make a Difference. The ADDF has one purpose: to eradicate Alzheimer’s so no other family has to live Ron and the Johnson family’s story. On November 3rd I am proudly running the New York City Marathon on behalf of Ron to fund research to advance drug discovery to treat Alzheimer’s. 100% of every dollar raised accelerates the development of solutions to slow the progression of the disease; all to make a difference in the lives of our loved ones battling the ailment. Please help me to advance drug discovery to slow the progression, and ultimately cure, Alzheimer’s. Together, we can honor Ron that we Made a Difference.
The ADDF is proud to be an official charity partner for the 2019 TCS New York City Marathon. Donations to our team, Runners for Alzheimer's Research, directly support research into new treatments for this devastating disease. In 2018, our team of runners from all over the world raised over $110,000. And 100% of the funds they raised went directly to Alzheimer's research.
Though we are making great strides, Alzheimer's remains the only top 10 cause of death in the U.S. that can't be prevented, cured or even slowed. By supporting drug discovery research, our marathon team will help conquer Alzheimer's!
Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the ADDF provides funding to leading scientists who are conducting the most promising, innovative Alzheimer’s drug research worldwide. The mission of the ADDF is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease.To learn more about the ADDF, please visit our website